RxAnte
Latest round
- Series A
Last raised
- Sep 2012
Total raised
- Undisclosed
Investors
- 2
About RxAnte
RxAnte, Inc.RxAnte, Inc. was founded in 2011 and is headquartered in Portland, US. The company specializes in Pharmacy Care Management, providing tailored medication management solutions. Loren Lidsky is the founder, while Josh Benner serves as the CEO.RxAnte specializes in providing innovative Pharmacy Care Management (PCM) solutions that aim to optimize medication use and improve health outcomes. The company's core offerings include a value-based pharmacy service called Mosaic, which targets at-risk members of health plans and providers to deliver tailored medication management strategies. RxAnte configures its patented analytics and software to the unique demographics of its client populations, ensuring that interventions are personalized and effective. The services are designed to enhance care quality while reducing healthcare costs, making them particularly valuable for health plans, providers, and pharmacies across various geographical markets, including the United States and potentially other regions with established healthcare systems.RxAnte generates revenue through its suite of PCM services, primarily via B2B arrangements with health plans and providers. The transactions typically occur as subscription-based partnerships, where clients pay for ongoing access to RxAnte's analytics platform and support services. This structure allows health plans to implement comprehensive medication management strategies while benefiting from continuous performance measurement. Key services, particularly the Mosaic pharmacy service and RxEFFECT® adherence workflow solution, are integral to these agreements, as they offer significant value in terms of quality improvement and cost reduction. The company is currently focused on enhancing its existing PCM solutions and launching new features aimed at improving medication management. Additionally, RxAnte is exploring opportunities to enter new geographic regions, aiming to establish a presence in markets beyond the United States by 2024. Financial terms were not disclosed.
Who invested in RxAnte
2 investors across 1 round
See all investors in RxAnte
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 12, 2012
Amount
Undisclosed
Investors
Questions about RxAnte
Who invested in RxAnte?
RxAnte has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RxAnte raised?
RxAnte has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did RxAnte last raise money?
RxAnte's most recent round on record is a Series A, in Sep 2012.
What does RxAnte do?
RxAnte is a healthcare it company.
Where is RxAnte headquartered?
RxAnte is headquartered in Portland, US.
Which VCs invest in companies like RxAnte?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at RxAnte's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like RxAnte? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.